{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-039375","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-08-20T12:30:43+00:00","discovered_at":"2026-08-20T12:35:00.473557+00:00","generated_at":"2026-08-20T12:35:20.093932+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"bioAffinity Technologies announces 1-for-15 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective at open of trading on Aug 24, 2026; every 15 shares become 1 share of BIAF.","Post-split shares outstanding ~592,373; new CUSIP 09076W406.","Split aims to meet Nasdaq minimum bid price requirement; no change to authorized shares or par value.","Proportionate adjustments made to outstanding stock options, RSUs, and warrants; fractional shareholders get cash.","Stockholders of record receive transfer agent notice; trading symbol remains BIAF."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-039375","json":"https://secwatch.observer/filing/0001493152-26-039375.json","markdown":"https://secwatch.observer/filing/0001493152-26-039375.md","text":"https://secwatch.observer/filing/0001493152-26-039375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226039375/0001493152-26-039375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226039375/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T12:35:20.093932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}